Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
We have established the organoids from intestinal metaplasia and fundic/pyloric gland by using the selection of culture condition and FACS, and then try to introduce several genomic abnormalities that are characteristic especially in gastric cancer (GC) using CRISPR/Cas9 system. We also generated the organoids from GC cases with intestinal and gastric mucin phenotype, respectively. It was found that GC organoids with intestinal mucin phenotype showed more significant resistance against 5-FU than GC organoids with gastric mucin phenotype.
|